|
English
|
正體中文
|
简体中文
|
總筆數 :2817890
|
|
造訪人次 :
27947125
線上人數 :
381
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"laus g"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-05-26T09:26:21Z |
Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M?�Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report
|
Chih-Hsin Yang;Shepherd F.A;Kim D.-W;Lee G.-W;Lee J.S;Chang G.-C;Lee S.S;Wei Y.-F;Lee Y.G;Laus G;Collins B;Pisetzky F;Horn L.; Chih-Hsin CHIH-HSIN YANG; Shepherd F.A; Kim D.-W; Lee G.-W; Lee J.S; Chang G.-C; Lee S.S; Wei Y.-F; Lee Y.G; Laus G; Collins B; Pisetzky F; Horn L. |
| 臺大學術典藏 |
2020-05-26T09:26:21Z |
Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M?�Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report
|
Chih-Hsin Yang;Shepherd F.A;Kim D.-W;Lee G.-W;Lee J.S;Chang G.-C;Lee S.S;Wei Y.-F;Lee Y.G;Laus G;Collins B;Pisetzky F;Horn L.; Chih-Hsin CHIH-HSIN YANG; Shepherd F.A; Kim D.-W; Lee G.-W; Lee J.S; Chang G.-C; Lee S.S; Wei Y.-F; Lee Y.G; Laus G; Collins B; Pisetzky F; Horn L. |
| 國立成功大學 |
2020 |
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
|
Papadimitrakopoulou, V.A.;Mok, T.S.;Han, J.-Y.;Ahn, M.-J.;Delmonte, A.;Ramalingam, S.S.;Kim, S.W.;Shepherd, F.A.;Laskin, J.;He, Y.;Akamatsu, H.;Theelen, W.S.M.E.;Su, W.-C.;John, T.;Sebastian, M.;Mann, H.;Miranda, Miranda M.;Laus, G.;Rukazenkov, Y.;Wu, Y.-L. |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
